Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 3/27/2024NMPA Holds National Conference on Drug Registration and Post-Market Re...
  • 3/27/2024NIFDC Issues the 2023 National Drug Sample Inspection Annual Report
  • 3/26/2024NMPA Publishes the 2023 Annual Report for Adverse Drug Reaction Monito...
  • 3/22/2024NMPA Announces Package Insert Revision of Multiple Drugs
  • 3/22/2024CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
  • 3/22/2024China Eases Cross-Border Data Transfer Rules to Alleviate Concerns of ...
  • 3/19/2024NDRC Issues 2024 Edition of the Guiding Catalog for Adjustment of Indu...
  • 3/18/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (80...
  • 3/12/2024CDE Issues the List of Reference Formulations for GQCE Studies (78th B...
  • 3/6/2024US Senate Committee Approves Bill That Could Restrict Chinese Biotech
  • 3/6/2024CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
  • 3/5/2024NMPA Announces Package Insert Revision of Synovitis Formulations
  • 2/29/2024CDE Issues the Technical Guidelines for Clinical Trial of Growth Hormo...
  • 2/23/2024NMPA Issues the Rules for the Application of Discretion in Administra...
  • 2/22/2024CDE Issues the Technical Guidelines for Non-Clinical Research on Enzym...
  • 2/21/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 2/21/2024CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
  • 2/21/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (79...
  • 2/19/2024CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
  • 2/8/2024China Issues the Action Plan for National Emergency Clinical Trials fo...
  • 2/7/2024CDE Issues the Technical Guidelines for Pharmaceutical Research on Mic...
  • 2/7/2024CDE Issues the Dossier References for Drug R&D and Technical Evaluatio...
  • 2/7/2024CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
  • 2/7/2024CDE Issues the List of Reference Formulations for GQCE Studies (77th B...
  • 2/7/2024NMPA Restores Import, Sales and Use of GSK's BPH Drug
  • 2/7/2024Boao Lecheng Pilot Zone Experiments Expedited Entry into China's Healt...
  • 2/7/2024China Proposes Accelerated Approval for Local Production of Biologics
  • 2/7/2024NMPA Issues the Pilot Reform Work Plan for Optimizing Drug Supplementa...
  • 2/6/2024NMPA and Chinese Customs Announce Addition of Hefei Airport as a Drug ...
  • 2/6/2024CDE Issues the Guidelines for Management and Review of Compliance Info...
  • Page:1/9 Total number of articles:259: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group